Cancer stem cells: Are we missing the target?

被引：147

作者：

Jones, RJ ^{[1
]}

Matsui, WH ^{[1
]}

Smith, BD ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 08期

关键词：

D O I：

10.1093/jnci/djh095

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：583 / 585

页数：3

共 31 条

[1] Prospective identification of tumorigenic breast cancer cells [J].

Al-Hajj, M ;

Wicha, MS ;

Benito-Hernandez, A ;

Morrison, SJ ;

Clarke, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988

[2]

BEDI A, 1993, BLOOD, V81, P2898

[3] THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].

BEN-NERIAH, Y ;

DALEY, GQ ;

MESMASSON, AM ;

WITTE, ON ;

BALTIMORE, D .

SCIENCE, 1986, 233 (4760) :212-214

[4] Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34+/CD71-/HLA-DR- [J].

Blair, A ;

Hogge, DE ;

Sutherland, HJ .

BLOOD, 1998, 92 (11) :4325-4335

[5] Chronic myeloid leukemia and interferon-α:: a study of complete cytogenetic responders [J].

Bonifazi, F ;

de Vivo, A ;

Rosti, G ;

Guilhot, F ;

Guilhot, J ;

Trabacchi, E ;

Hehlmann, R ;

Hochhaus, A ;

Shepherd, PCA ;

Steegmann, JL ;

Kluin-Nelemans, HC ;

Thaler, J ;

Simonsson, B ;

Louwagie, A ;

Reiffers, J ;

Mahon, FX ;

Montefusco, E ;

Alimena, G ;

Hasford, J ;

Richards, S ;

Saglio, G ;

Testoni, N ;

Martinelli, G ;

Tura, S ;

Baccarani, M .

BLOOD, 2001, 98 (10) :3074-3081

[6] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[7] INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].

DALEY, GQ ;

VANETTEN, RA ;

BALTIMORE, D .

SCIENCE, 1990, 247 (4944) :824-830

[8] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[9] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].

Druker, BJ ;

Tamura, S ;

Buchdunger, E ;

Ohno, S ;

Segal, GM ;

Fanning, S ;

Zimmermann, J ;

Lydon, NB .

NATURE MEDICINE, 1996, 2 (05) :561-566

[10] Detection of leukemic cells in the CD34+CD38- bone marrow progenitor population in children with acute lymphoblastic leukemia [J].

George, AA ;

Franklin, J ;

Kerkof, K ;

Shah, AJ ;

Price, M ;

Tsark, E ;

Bockstoce, D ;

Yao, DP ;

Hart, N ;

Carcich, S ;

Parkman, R ;

Crooks, GM ;

Weinberg, K .

BLOOD, 2001, 97 (12) :3925-3930

← 1 2 3 4 →